Abstract submission extended!

Good news: The submission deadline for the 71st Meeting of the Society of Thrombosis and Haemostasis Research has been extended until 5 November 2026 — giving you a bit more time to finalize and submit your abstract. Don’t miss the chance to be part of this important scientific exchange!

Important Dates

  • 5 November 2026: Abstract submission closes
  • Beginning of December 2026: Abstract notifications sent to authors

Submission Categories

Subject areas:
1. Basic & Translational Science
– Basic Research in Thrombosis and Haemostasis
– Biophysics of Thrombosis and Haemostasis
– Endothelium and Vascular Biology
– Fibrin and Fibrinolysis
– Platelets
– von Willebrand Factor (VWF) and ADAMTS13

2. Disorders of Haemostasis
– Antiphospholipid Syndrome
– Hemophilia
– Platelet Disorders and Novel Treatments
– Rare Bleeding Disorders (e.g. Ehlers-Danlos Syndrome, Hereditary Hemorrhagic Telangiectasia)
– Thrombotic Microangiopathies (e.g. TTP)
– von Willebrand Disease (VWD) 

3. Thrombosis and Haemostasis & Associated Conditions
– Haemostasis and Immunology
– Immunothrombosis / Thromboinflammation / Infection
– Thrombosis and Cancer
– Thrombosis in Autoimmune and Rheumatologic Diseases
– Thrombosis in Cardiovascular and Neurological Diseases 

4. Clinical Management & Therapeutics
– Anticoagulation in Patients with Bleeding Disorders
– Anticoagulation: Therapeutic Strategies and Off-label Use
– Laboratory Diagnostics and Monitoring
– Perioperative Management 

5. Population-Specific Haemostasis
– Haemostasis in the Elderly
– Paediatric Haemostasis
– Women’s Haemostasis (incl. Pregnancy & Postpartum Haemorrhage) 

6. Haemostasis in Special Clinical Settings
– Critical Care and Traumatology
– Hepatology and Haemostasis
– Orthopaedics and Musculoskeletal Haemostasis

7. Genetics & Phenotypes
– Genetics and Clinical Presentation 

8. Digital & Precision Medicine in Haemostasis
– Artificial Intelligence and Data-driven Haemostasis
– Biomarkers and Risk Stratification
– Genomics, Proteomics and Multi-omics Approaches
– Personalised and Precision Medicine 

Abstract Guidelines

  • Abstract text is limited to 3,000 characters including spaces
  • Submission language is English
  • Please structure your abstract as follows:
    • Introduction
    • Method
    • Results
    • Conclusion
    • Conflict of interest
    • References
  • You can upload up to two items (table and/or image) to your abstract.
  • Please choose 1 of the subject areas for your abstract
  • Encore abstracts are allowed.
  • Please check spelling and grammar carefully. All abstracts will be published as submitted
  • Use generic names. Commercial drug names may not be used
  • Please note, the presenting author will need to be registered and attending GTH 2027.